Cargando…
Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy
BACKGROUND: Trastuzumab (T) and anthracycline (A)-based chemotherapy is considered the standard of care in human epidermal growth factor receptor-2+ overexpressing breast cancer, but requires monitoring for known cardiotoxicity using left ventricular (LV) ejection fraction (EF) every 3–4 months duri...
Autores principales: | Klein, Ran, Nadouri, Doaa, Osler, Erin, Johnson, Christopher, Dent, Susan, Dwivedi, Girish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282666/ https://www.ncbi.nlm.nih.gov/pubmed/30418380 http://dx.doi.org/10.1097/MNM.0000000000000941 |
Ejemplares similares
-
Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
por: Reuvekamp, E. J., et al.
Publicado: (2015) -
Diastolic And Systolic Right Ventricular Dysfunction Precedes Left Ventricular Dysfunction In Patients Paced From Right Ventricular Apex
por: Dwivedi, SK, et al.
Publicado: (2006) -
Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010) -
Diastolic dysfunction precedes hypoxia-induced mortality in dystrophic mice
por: Townsend, DeWayne
Publicado: (2015) -
Layer-specific systolic and diastolic strain in hypertensive patients with and without mild diastolic dysfunction
por: Sharif, Hisham, et al.
Publicado: (2018)